Literature DB >> 16781037

Health care costs in the last year of life--the Dutch experience.

Johan J Polder1, Jan J Barendregt, Hans van Oers.   

Abstract

Health expenditure depends heavily on age. Common wisdom is that the age pattern is dominated by costs in the last year of life. Knowledge about these costs is important for the debate on the future development of health expenditure. According to the 'red herring' argument traditional projection methods overestimate the influence of ageing because improvements in life expectancy will postpone rather than raise health expenditure. This paper has four objectives: (1) to estimate health care costs in the last year of life in the Netherlands; (2) to describe age patterns and differences between causes of death for men and women; (3) to compare cost profiles of decedents and survivors; and (4) to use these figures in projections of future health expenditure. We used health insurance data of 2.1 million persons (13% of the Dutch population), linked at the individual level with data on the use of home care and nursing homes and causes of death in 1999. On average, health care costs amounted to 1100 Euro per person. Costs per decedent were 13.5 times higher and approximated 14,906 Euro in the last year of life. Most costs related to hospital care (54%) and nursing home care (19%). Among the major causes of death, costs were highest for cancer (19,000 Euro) and lowest for myocardial infarctions (8068 Euro). Between the other causes of death, however, cost differences were rather limited. On average costs for the younger decedents were higher than for people who died at higher ages. Ten per cent of total health expenditure was associated with the health care use of people in their last year of life. Increasing longevity will result in higher costs because people live longer. The decline of costs in the last year of life with increasing age will have a moderate lowering effect. Our projection demonstrated a 10% decline in the growth rate of future health expenditure compared to conventional projection methods.

Entities:  

Mesh:

Year:  2006        PMID: 16781037     DOI: 10.1016/j.socscimed.2006.04.018

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  50 in total

1.  Health care costs during the last 12 months of life in Israel: estimation and implications for risk-adjustment.

Authors:  Amir Shmueli; David Messika; Irit Zmora; Bernice Oberman
Journal:  Int J Health Care Finance Econ       Date:  2010-05-22

2.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

Review 3.  The effect of population aging on health expenditure growth: a critical review.

Authors:  Claudine de Meijer; Bram Wouterse; Johan Polder; Marc Koopmanschap
Journal:  Eur J Ageing       Date:  2013-05-15

4.  [Ageing, medical progress and the growth of healthcare expenditure].

Authors:  F Breyer
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

5.  Care service use in 2 years preceding suicide among older adults: comparison with those who died a natural death and those who lived longer.

Authors:  Leena Forma; Mari Aaltonen; Jutta Pulkki; Jani Raitanen; Pekka Rissanen; Marja Jylhä
Journal:  Eur J Ageing       Date:  2016-10-04

6.  Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.

Authors:  H Amarens Geuzinge; Inge-Marie Obdeijn; Emiel J T Rutgers; Sepideh Saadatmand; Ritse M Mann; Jan C Oosterwijk; Rob A E M Tollenaar; Diderick B W de Roy van Zuidewijn; Marc B I Lobbes; Martijne van 't Riet; Maartje J Hooning; Margreet G E M Ausems; Claudette E Loo; Jelle Wesseling; Ernest J T Luiten; Harmien M Zonderland; Cees Verhoef; Eveline A M Heijnsdijk; Madeleine M A Tilanus-Linthorst; Harry J de Koning
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

7.  Micro data analysis of medical and long-term care utilization among the elderly in Japan.

Authors:  Hideki Hashimoto; Hiromasa Horiguchi; Shinya Matsuda
Journal:  Int J Environ Res Public Health       Date:  2010-07-30       Impact factor: 3.390

8.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

9.  Comparison of end-of-life care for older people living at home and in residential homes: a mortality follow-back study among GPs in the Netherlands.

Authors:  Yolanda W H Penders; Lieve Van den Block; Gé A Donker; Luc Deliens; Bregje Onwuteaka-Philipsen
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

10.  Direct costs associated with the appropriateness of hospital stay in elderly population.

Authors:  Joaquín F Mould-Quevedo; Carmen García-Peña; Iris Contreras-Hernández; Teresa Juárez-Cedillo; Claudia Espinel-Bermúdez; Gabriela Morales-Cisneros; Sergio Sánchez-García
Journal:  BMC Health Serv Res       Date:  2009-08-22       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.